Interpace Biosciences Announces Third Quarter 2026 Financial and Business Results
Q3 Revenue of $10.4 million Q3 Thyroid volume year-over-year increase of 7% Q3 Thyroid revenue year
Q3 Revenue of $10.4 million Q3 Thyroid volume year-over-year increase of 7% Q3 Thyroid revenue year